1-1 of 1
phosphatidylinositide 3-kinase inhibitors
Close
Sort by
Journal Articles

The dual PI3Kδ/CK1ε inhibitor umbralisib exhibits unique immunomodulatory effects on CLL T cells

Kamira Maharaj, John J. Powers, Alex Achille, Melanie Mediavilla-Varela, Wael Gamal, Karen L. Burger, Renee Fonseca, Kun Jiang, Hari P. Miskin, Dave Maryanski, Andrii Monastyrskyi, Derek R. Duckett, William R. Roush, John L. Cleveland, Eva Sahakian, Javier Pinilla-Ibarz
Journal: Blood Advances
Blood Adv (2020) 4 (13): 3072–3084.
https://doi.org/10.1182/bloodadvances.2020001800
Published: 2020
Includes: Supplemental data